Palo Alto, CA, United States of America

Xia Yia


Average Co-Inventor Count = 27.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xia Yia in Pharmaceutical Chemistry

Introduction

Xia Yia is a prominent inventor based in Palo Alto, CA, known for her contributions to pharmaceutical chemistry. She has made significant strides in the development of new compounds that have potential therapeutic applications. Her work is particularly focused on substituted imidazole derivatives, which are crucial in the field of medicinal chemistry.

Latest Patents

Xia Yia holds a patent for "Substituted imidazole derivatives." This invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters, or prodrugs thereof. The patent also covers compositions of these new compounds along with pharmaceutically acceptable carriers and their uses. The compounds of the invention have a general formula that showcases their innovative structure and potential applications in medicine.

Career Highlights

Xia Yia is currently employed at Novartis Vaccines & Diagnostics GmbH, where she continues to advance her research in pharmaceutical innovations. Her work at Novartis has allowed her to collaborate with leading experts in the field and contribute to the development of new therapeutic solutions.

Collaborations

Xia has worked alongside notable colleagues such as Weibo Wang and Paul Andrew Barsanti. These collaborations have enriched her research and expanded the impact of her inventions in the pharmaceutical industry.

Conclusion

Xia Yia's innovative work in the field of pharmaceutical chemistry, particularly her patent on substituted imidazole derivatives, highlights her significant contributions to medical science. Her ongoing research at Novartis Vaccines & Diagnostics GmbH continues to pave the way for new therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…